Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Dev Vct Regulatory News (AADV)

  • This share is currently suspended. It was suspended at a price of 85.00
  • There is currently no data for AADV

Albion Development VCT PLC: Interim Management Statement

27 Nov 2024 12:45

Albion Development VCT PLC: Interim Management Statement

ALBION DEVELOPMENT VCT PLC LEI Code 213800FDDMBD9QLHLB38 Interim Management Statement

Introduction I present Albion Development VCT PLC (the “Company”)’s interim management statement for the period from 1 July 2024 to 30 September 2024.

Performance and dividends The Company's unaudited net asset value (“NAV”) on 30 September 2024 was £137.20 million or 92.27 pence per share (excluding treasury shares). After accounting for the dividend of 2.40 pence per share paid on 30 September 2024 to shareholders on the register on 13 September 2024, this is a decrease of 1.24 pence per share (1.33%) since 30 June 2024.

After accounting for the special dividend of 3.00 pence per share paid on 25 October 2024 to shareholders on the register on 4 October 2024, the NAV is 89.27 pence per share.

Share issues During the period from 1 July 2024 to 30 September 2024, the Company issued the following shares under the dividend reinvestment scheme:

DateNumber of shares issuedIssue price per shareNet invested £’000
30 September 2024601,45293.51p542

Albion VCTs Mergers On 12 November 2024, the Company issued a circular, jointly with the other Albion managed VCTs, proposing, amongst other things, the merger of the Company with Albion Enterprise VCT PLC.

The key reasons for the proposed mergers are the significant benefits it brings to shareholders including costs savings, simplified fee structure across the Albion VCTs, reduced administration and streamlined fundraising offers.

The circular includes Notices of the General Meetings to be held at 12 noon on 11 December 2024 and at 10 a.m. on 19 December 2024. The Board have all cast their votes, and encourage all shareholders to vote, if they haven’t already, in favour of the resolutions to be proposed at the General Meetings in connection with the recommended proposals.

Further details of the benefits of the proposed merger to shareholders can be found in the circular, which can be viewed at www.albion.capital/mergers.

Portfolio The following investments have been made during the period from 1 July 2024 to 30 September 2024:

Further investments£’000sActivity
Infact Systems359Technology for credit assessment
Kennek Solutions277Vertical software for lenders
Mondra Global267Food supply chain emissions modelling
Diffblue173AI for code testing/writing platform
OpenDialog AI171AI powered chatbots and virtual assistants
PeakData126Provides insights and analytics to pharmaceutical companies about therapeutic areas
Total further investments1,373 

Top ten holdings as at 30 September 2024:

Portfolio CompanyCarrying value £000s% of net asset valueActivity
Quantexa27,85320.3Network analytics platform to detect financial crime
Proveca10,4757.6Reformulation of medicines for children
Oviva5,3203.9A technology enabled service business in medical nutritional therapy (MNT)
Panaseer3,2582.4Provider of cyber security services
The Evewell Group3,0112.2Operator and developer of women’s health centres focusing on fertility
Radnor House School (TopCo)2,8502.1Independent school for children aged 2-18
Healios2,6741.9Provider of an online platform delivering family centric psychological care primarily to children and adolescents
Gravitee TopCo2,3831.7API management platform
The Street by Street Solar Programme2,1331.6Owner and operator of photovoltaic systems on domestic properties in the UK
Runa Network2,0731.5Cloud platform and infrastructure that enables corporates to issue digital incentives and payouts

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/vct-funds/AADV.

Share buy-backs During the period from 1 July 2024 to 30 September 2024, the Company purchased 757,508 shares for £660,000 (including stamp duty) at a price of 86.72 pence per share. All the shares were cancelled.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for such buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.

Material events and transactions after the period end Other than the circular issued on 12 November 2024 as detailed above, there have been no other material events or transactions after the period end to the date of this announcement.

Further information Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/vct-funds/AADV.

Ben Larkin, Chairman 27 November 2024

For further information please contact: Vikash Hansrani Operations Partner Albion Capital Group LLP Telephone: 020 7601 1850

Date   Source Headline
7th Apr 20084:55 pmRNSFinal Results
31st Mar 20085:06 pmRNSTotal Voting Rights
29th Feb 20085:26 pmRNSTotal Voting Rights
31st Jan 20084:42 pmRNSTotal Voting Rights
3rd Jan 20084:21 pmRNSTotal Voting Rights
2nd Jan 20085:13 pmRNSDirectorate Change
17th Dec 20075:19 pmRNSTransaction in Own Shares
30th Nov 20075:08 pmRNSTotal Voting Rights
21st Nov 20075:11 pmRNSTransaction in Own Shares
20th Nov 20075:30 pmRNSTransaction in Own Shares
15th Nov 20071:04 pmRNSNet Asset Value(s)
5th Nov 20073:31 pmRNSTransaction in Own Shares
2nd Nov 20071:05 pmRNSDirectorate Change
31st Oct 20074:51 pmRNSTotal Voting Rights
1st Oct 20074:21 pmRNSTotal Voting Rights
28th Sep 20079:55 amRNSTransaction in Own Shares
20th Sep 20075:29 pmRNSTransaction in Own Shares
13th Sep 20075:23 pmRNSTransaction in Own Shares
10th Sep 20075:33 pmRNSTransaction in Own Shares
3rd Sep 20075:20 pmRNSTotal Voting Rights
30th Aug 200712:25 pmRNSInterim Results
1st Aug 20074:36 pmRNSTotal Voting Rights
13th Jul 200710:59 amRNSNet Asset Value(s)
2nd Jul 20071:15 pmRNSDirectorate Change
2nd Jul 200711:35 amRNSTotal Voting Rights
29th Jun 20071:34 pmRNSTransaction in Own Shares
7th Jun 20074:34 pmRNSTransaction in Own Shares
1st Jun 200711:26 amRNSTotal Voting Rights
29th May 200712:36 pmRNSEGM Statement
23rd May 20074:00 pmRNSTransaction in Own Shares
21st May 20074:01 pmRNSTransaction in Own Shares
16th May 20075:14 pmRNSTransaction in Own Shares
11th May 20075:10 pmRNSTransaction in Own Shares
2nd May 200711:55 amRNSNotice of EGM
1st May 20074:58 pmRNSTransaction in Own Shares
1st May 20074:47 pmRNSTotal Voting Rights
13th Apr 20074:45 pmRNSTransaction in Own Shares
12th Apr 20072:40 pmRNSTransaction in Own Shares
11th Apr 20073:35 pmRNSNet Asset Value(s)
2nd Apr 20075:21 pmRNSTransaction in Own Shares
2nd Apr 20079:22 amRNSTotal Voting Rights
29th Mar 200711:26 amRNSBonus Issue and Conversion
27th Mar 200710:23 amRNSNAV and dividend declaration
16th Mar 200711:28 amRNSAnnual Information Update
14th Mar 20072:23 pmRNSDoc re: Final Accounts
12th Mar 200710:42 amRNSDirectorate Change
5th Mar 20073:37 pmRNSNet Asset Value(s)
1st Mar 20073:31 pmRNSTotal Voting Rights
1st Mar 20071:51 pmRNSFinal Results
1st Feb 20075:12 pmRNSVoting rights and capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.